Improving Remote Breathalyzer Procedures Used by Clinicians and Researchers to Remotely Monitor Alcohol Use
1 other identifier
observational
60
1 country
1
Brief Summary
Remote breath alcohol monitors have been increasingly adopted for use in clinical, research and forensic settings to monitor alcohol use because they offer several key advantages over other available monitoring methods. However, it remains unknown if remote breathalyzers reliably detect alcohol use because there is up to a 10-hour window of time when breath samples are not obtained (to allow for sleeping). Additionally, the investigators will examine whether a supplemental measurement of a blood alcohol use biomarker (phosphatidylethanol) can confirm abstinence and/or detect individuals engaging in late-evening drinking to avoid the negative consequences associated with detected alcohol use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 15, 2022
CompletedFirst Posted
Study publicly available on registry
December 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedMay 10, 2024
May 1, 2024
2 years
November 15, 2022
May 9, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Transdermal Alcohol Content
Measurement produced while wearing Transdermal Alcohol Monitor
They will be placed on the device starting at the first visit and wear it for four weeks till the last visit.
Measurement of Phosphatidylethanol
Measuring Phosphatidylethanol via blood spot cards. THis is a measurement of alcohol use.
Once every week for four weeks.
Study Arms (1)
Monitoring Group
Participants will be monitored via a transdermal monitor for four weeks. They will give four breath samples a day for these weeks as well as 5 Blood spot samples.
Interventions
Eligibility Criteria
The study population is consisted of members of the DFW metroplex.
You may qualify if:
- ≥ 21 years of age
- Either convicted of a DWI offense in the past 2 years but not court-mandated to undergo continuous alcohol monitoring or reporting driving while intoxicated in the past year or report ≥ 10 heavy drinking episodes during the past month (heavy drinking episodes count as more than 3 drinks in a day for females and 4 or more alcoholic drinks in a day in a male).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Texas
Denton, Texas, 76203, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department Chair
Study Record Dates
First Submitted
November 15, 2022
First Posted
December 7, 2022
Study Start
August 1, 2022
Primary Completion
July 31, 2024
Study Completion
July 31, 2024
Last Updated
May 10, 2024
Record last verified: 2024-05